Evaluación de una propuesta de criterios de indicación de densitometría ósea en mujeres posmenopáusicas españolas basados en la herramienta FRAX®

Gómez-Vaquero, Carmen; Roig-Vilaseca, Daniel; Bianchi, Martha S.; Santo, Pilar; Narváez, Javier; Nolla, Joan M.

doi:10.1016/j.medcli.2012.03.008

Cited by 11 publications

(4 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite the significant influence of BMD on the overall risk of fracture, several studies have shown that taken in isolation, it fails to deliver a cost-effective population screening test [7][8][9] . The current practice in most developed countries is to identify patients at high risk of fragility fractures taking into account the presence of other risk factors besides densitometric osteoporosis [9][10][11][12][13][14] .…”

Section: Introductionmentioning

confidence: 99%

Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?

Azagra¹,

Zwart

Aguyé

et al. 2016

Maturitas

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?

Azagra¹,

Zwart

Aguyé

et al. 2016

Maturitas

View full text Add to dashboard Cite

“…On the other hand, extrapolating our results to those from other populations might not always be possible. For instance, it has been shown that while FRAX is a useful tool to estimate future risk of hip fracture, it seems to underestimate the risk of major osteoporosis fracture in the Spanish postmenopausal women [ 43 ].…”

Section: Discussionmentioning

confidence: 99%

Spanish National Registry of Major Osteoporotic Fractures (REFRA) seen at Fracture Liaison Services (FLS): objectives and quality standards

et al. 2022

View full text Add to dashboard Cite

Summary REFRA-FLS is a new registry in Spain aimed at identifying individuals over 50 years of age with a fragility fracture. Using this registry, we found hip fracture is the most prevalent fracture. Treatment for osteoporosis was 87.7%, with 65.3% adherence. REFRA-FLS provides fundamental data in the study of fragility fractures. Purpose Fragility fractures are a growing public health concern in modern-aged societies. Fracture Liaison Services (FLS) have been shown to successfully lower rates of secondary fractures. A new registry (REFRA-FLS) has been created to monitor quality indicators of FLS units in Spain and to explore the occurrence and characteristic of fragility fractures identified by these centers. Methods We conducted a prospective cohort study based on fragility fractures recorded in the REFRA-FLS registry. Participants were individuals 50 years or above who suffered a low energy fragility fracture identified by the 10 participating FLS units during the study period. The type of FLS unit, the characteristics of the individuals at baseline, along with patient outcomes as quality indicators among those who completed 1 year of follow-up were analyzed. Results A total of 2965 patients and 3067 fragility fractures were identified, and the most frequent locations were hip (n = 1709, 55.7%) and spine (n = 492, 16.0%). A total of 43 refractures (4.5%) and 46 deaths (4.9%) were observed among 948 individuals in the follow-up analyses. Time from fracture to evaluation was less than 3 months in 76.7% of individuals. Osteoporosis treatment was prescribed in 87.7%, and adherence was 65.3% in Morisky–Green test. Conclusion Our results provide a comprehensive picture of fragility fractures identified in FLS units from Spain. Overall, quality indicators are satisfactory although a much higher use of DXA would be desirable. As the registry grows with the incorporation of new FLS units and longer follow-up, incoming analyses will provide valuable insight.

show abstract

“…El riesgo de fractura de una mujer americana de 65 años es del 9,3%, según las tablas FRAX ® , y el riesgo de fractura de una mujer española es del 3,6%. Algunos autores, en una interpretación errónea, proponen como umbral de intervención para justificar la realización de densitometrías esta cifra del 3,6% 9 , y como umbral de intervención farmacológica por consenso el 10%. Con este criterio se trataría a muchas mujeres con escaso riesgo.…”

unclassified

Osteoporosis: cómo, cuándo y hasta dónde

García-Franco

2016

Atención Primaria

View full text Add to dashboard Cite

Evaluación de una propuesta de criterios de indicación de densitometría ósea en mujeres posmenopáusicas españolas basados en la herramienta FRAX®

Cited by 11 publications

References 25 publications

Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?

Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?

Spanish National Registry of Major Osteoporotic Fractures (REFRA) seen at Fracture Liaison Services (FLS): objectives and quality standards

Osteoporosis: cómo, cuándo y hasta dónde

Contact Info

Product

Resources

About